Chandrima Sanyal
·
July 26, 2025
Benzinga
Sci-fi becomes reality: AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants.
read more
September 19, 2025
September 5, 2025
July 10, 2025
Financial Times
June 23, 2025
August 10, 2025